CREUTZFELDT-JAKOB DISEASE A CASE REPORT
Main Article Content
Abstract
Creutzfeldt-Jakob Disease (CJD) is a rare, progressive neurodegenerative disorder that is typically fatal within one year of clinical onset. The disease's pathogenesis is caused by prion proteins. The global incidence of CJD is approximately 1-2 cases per million population. To date, there is no effective treatment for CJD. Early diagnosis plays a crucial role in providing optimal palliative care for patients. We report a case of a 58-year-old female patient who presented one month before hospital admission with sudden onset headache, dizziness, and focal seizures affecting the right hand. Her clinical symptoms rapidly progressed to impaired consciousness, memory dysfunction, cerebellar ataxia, and dysarthria. Brain MRI revealed hyperintense signals in the left cerebral cortex and right frontal lobe. Electroencephalography (EEG) showed periodic slow waves and triphasic waves. Cerebrospinal fluid analysis detected the presence of the 14-3-3 protein. The patient was diagnosed with probable CJD and received symptomatic treatment, including neuroprotective and nutritional support. Upon discharge, she was provided with instructions for care and treatment at the local healthcare level.
Article Details
Keywords
Creutzfeldt-Jakob, neurodegeneration, prion protein.
References
2. Noor H, Baqai MH, Naveed H, et al. Creutzfeldt-Jakob disease: A comprehensive review of current understanding and research. J Neurol Sci. 2024; 467:123293.
3. Rus T, Lorber B, Trošt M, et al. High incidence of Sporadic Creutzfeldt-Jakob disease in Slovenia in 2015: A case series. Dement Geriatr Cogn Dis Extra. 2018; 8(1):42-50.
4. Kojima G, Tatsuno BK, Inaba M, et al. Creutzfeldt-Jakob disease: A case report and differential diagnoses. Hawaii J Med Public Health. 2013; 72(4):136-139.
5. Creutzfeldt-Jakob Disease Classic (CJD) US centers for disease control and prevention website. Updated September 10, 2021. December 22, 2024. https://www.cdc.gov/prions/cjd/index.html.
6. Behaeghe O, Mangelschots E, De Vil B, et al. A systematic review comparing the diagnostic value of 14-3-3 protein in the cerebrospinal fluid, RT-QuIC and RT-QuIC on nasal brushing in sporadic Creutzfeldt-Jakob disease. Acta Neurol Belg. 2018; 118(3):395-403.
7. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004; 63(3):443-449.
8. Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol. 2006; 117(5):935-951.
9. Caobelli F, Cobelli M, Pizzocaro C, et al. The role of neuroimaging in evaluating patients affected by Creutzfeldt- Jakob disease: A systematic review of the literature. J Neuroimaging. 2015; 25(1):2-13.